Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HUMBERT

Showing results (71-80 of 251) with videos related to

Pageof 26
Sort By:
European Annals of Otorhinolaryngology, Head and Neck Diseases|April 16, 2020
Routine feasibility of postoperative chemoradiotherapy in head and neck squamous cell carcinoma at high risk of recurrenceM Humbert, M De La Losa, B Gery, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Visualization of activation-dependent epitopes on glycoprotein IIb-IIIa complexes of platelets stimulated by thrombin: immunogold staining of ultrathin sectionsM Humbert, T J Kunicki, C Bihour, et al.
Revue Des Maladies Respiratoires|February 24, 2023
[Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease]F Robert, N Berrebeh, C Guignabert, et al.
Revue Des Maladies Respiratoires|March 16, 2011
[Surgical treatment of pulmonary arterial hypertension]E Fadel, O Mercier, S Mussot, et al.
Blood|September 6, 2001
The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawalT S Migone, M Humbert, A Rascle, et al.
Thorax|April 30, 2004
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertensionA Chaouat, F Coulet, C Favre, et al.
Revue Des Maladies Respiratoires|May 1, 2012
[HIV-related pulmonary arterial hypertension]L Savale, F Lador, X Jais, et al.
Revue Medicale Suisse|December 25, 2014
[Vulnerable older patients in primary care how to identify them? Which ressources to mobilize? ]C Smith, E Rubli, N Senn, et al.
European Journal of Clinical Investigation|August 22, 2006
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defectsO Sitbon, M Beghetti, J Petit, et al.
Thorax|April 9, 1999
Urinary cGMP concentrations in severe primary pulmonary hypertensionM Bogdan, M Humbert, J Francoual, et al.
Pageof 26

Showing results (71-80 of 251) with videos related to

Sort By:
Pageof 26
European Annals of Otorhinolaryngology, Head and Neck Diseases|April 16, 2020
Routine feasibility of postoperative chemoradiotherapy in head and neck squamous cell carcinoma at high risk of recurrenceM Humbert, M De La Losa, B Gery, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Visualization of activation-dependent epitopes on glycoprotein IIb-IIIa complexes of platelets stimulated by thrombin: immunogold staining of ultrathin sectionsM Humbert, T J Kunicki, C Bihour, et al.
Revue Des Maladies Respiratoires|February 24, 2023
[Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease]F Robert, N Berrebeh, C Guignabert, et al.
Revue Des Maladies Respiratoires|March 16, 2011
[Surgical treatment of pulmonary arterial hypertension]E Fadel, O Mercier, S Mussot, et al.
Blood|September 6, 2001
The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawalT S Migone, M Humbert, A Rascle, et al.
Thorax|April 30, 2004
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertensionA Chaouat, F Coulet, C Favre, et al.
Revue Des Maladies Respiratoires|May 1, 2012
[HIV-related pulmonary arterial hypertension]L Savale, F Lador, X Jais, et al.
Revue Medicale Suisse|December 25, 2014
[Vulnerable older patients in primary care how to identify them? Which ressources to mobilize? ]C Smith, E Rubli, N Senn, et al.
European Journal of Clinical Investigation|August 22, 2006
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defectsO Sitbon, M Beghetti, J Petit, et al.
Thorax|April 9, 1999
Urinary cGMP concentrations in severe primary pulmonary hypertensionM Bogdan, M Humbert, J Francoual, et al.
Pageof 26